Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients

Journal of the Neurological Sciences

Volumn 281, Issue 1-2, 2009, Pages 69-73

  Nam, Hyo Suk ^a   Lee, Kyung Yul ^a   Han, Sang Won ^a   Kim, Seo Hyun ^a   Lee, Jong Yun ^a   Ahn, Seong Hwan ^a   Kim, Dong Joon ^a   Kim, Dong Ik ^a   Nam, Chung Mo ^a   Heo, Ji Hoe ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ischemic stroke; Outcome; ROC curve; Thrombolysis

Indexed keywords

ALTEPLASE; UROKINASE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RECANALIZATION; ROC CURVE; STROKE; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CAROTID ARTERY DISEASES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; ROC CURVE; SEVERITY OF ILLNESS INDEX; SMOKING; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67349102293     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.02.365     Document Type: Article

References (26)

1. Prabhakaran S., Chen M., Choi J.H., Mangla S., Lavine S.D., Pile-Spellman J., et al. Major neurologic improvement following endovascular recanalization therapy for acute ischemic stroke. Cerebrovasc Dis 25 (2008) 401-407
2. Broderick J.P., Lu M., Kothari R., Levine S.R., Lyden P.D., Haley E.C., et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke 31 (2000) 2335-2341
3. Brown D.L., Johnston K.C., Wagner D.P., and Haley Jr. E.C. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 35 (2004) 147-150
4. Saposnik G., Di Legge S., Webster F., and Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 65 (2005) 1169-1174
5. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28 (1997) 2119-2125
6. Demchuk A.M., Tanne D., Hill M.D., Kasner S.E., Hanson S., Grond M., et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 57 (2001) 474-480
7. del Zoppo G.J., Poeck K., Pessin M.S., Wolpert S.M., Furlan A.J., Ferbert A., et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 (1992) 78-86
8. Lee K.Y., Han S.W., Kim S.H., Nam H.S., Ahn S.W., Kim D.J., et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 38 (2007) 192-193
9. Nam H.S., Han S.W., Ahn S.H., Lee J.Y., Choi H.Y., Park I.C., et al. Improved time intervals by implementation of computerized physician order entry-based stroke team approach. Cerebrovasc Dis 23 (2007) 289-293
10. Lee K.Y., Kim D.I., Kim S.H., Lee S.I., Chung H.W., Shim Y.W., et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 25 (2004) 1470-1475
11. Heo J.H., Lee K.Y., Kim S.H., and Kim D.I. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study. Neurology 60 (2003) 1684-1687
12. Lee K.Y., Heo J.H., Lee S.I., and Yoon P.H. Rescue treatment with abciximab in acute ischemic stroke. Neurology 56 (2001) 1585-1587
13. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76 (1987) 142-154
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
15. Haley Jr. E.C., Lewandowski C., and Tilley B.C. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med 30 (1997) 676-682
16. Alexandrov A.V., Demchuk A.M., Felberg R.A., Christou I., Barber P.A., Burgin W.S., et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 31 (2000) 610-614
17. Park S.H., Goo J.M., and Jo C.H. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol 5 (2004) 11-18
18. Mikulik R., Ribo M., Hill M.D., Grotta J.C., Malkoff M., Molina C., et al. Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation 115 (2007) 2660-2665
19. Tsivgoulis G., and Alexandrov A. Ultrasound enhanced thrombolysis: applications in acute cerebral ischemia. J Clin Neurol 3 (2007) 1-8
20. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 (1997) 2109-2118
21. Ovbiagele B., and Saver J.L. The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 65 (2005) 293-295
22. Bang O.Y., Park H.Y., Lee P.H., Kim G.M., Chung C.S., and Lee K.H. Improved outcome after atherosclerotic stroke in male smoker. J Neurol Sci 260 (2007) 43-48
23. Ciccone A., Valvassori L., Gasparotti R., Scomazzoni F., Ballabio E., and Sterzi R. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 38 (2007) 2191-2195
24. Qureshi A.I., Kirmani J.F., Sayed M.A., Safdar A., Ahmed S., Ferguson R., et al. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology 64 (2005) 2115-2120
25. Rha J.H., and Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38 (2007) 967-973
26. Fleming T.R., and DeMets D.L. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 125 (1996) 605-613